SNNC (Sibannac) Notes Receivable: $0.00 Mil (As of Feb. 2017)


What is Sibannac Notes Receivable?

Sibannac SNNC -29.41% Notes Receivable is $0.00 Mil as of Feb. 2017.

Sibannac's Notes Receivable for the quarter that ended in Feb. 2017 was $0.00 Mil.

Sibannac Notes Receivable Historical Data

* Premium members only.

The historical data trend for Sibannac's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sibannac Notes Receivable Chart

Sibannac Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sibannac Quarterly Data
May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sibannac Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Sibannac (SNNC) has a Notes Receivable of $0.00 Mil as of Feb. 2017. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sibannac and its competitors.
Is Sibannac's Notes Receivable too high?
Sibannac's current Notes Receivable is $0.00 Mil.
How does Sibannac's Notes Receivable compare to LIVC and OTTV?
Sibannac's Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sibannac and its competitors. Sibannac's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sibannac stock overvalued right now?
Sibannac (SNNC) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Sibannac (SNNC), the current Notes Receivable is $0.00 Mil as of Feb. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sibannac Business Description

Address 8657 N Caballo Circle, Paradise Valley, AZ, USA, 85253
Sibannac Inc is a cannabis research and development company with a portfolio of hemp beauty and body products, hemp animal care products, hemp clothing and accessories, and hemp paper and plastic products. Its products include oils, creams, lotions, treats, foods, shirts, pants, and dresses, and it also develops new hemp products. The group manufactures its products in Geneva, New York, and Charlotte, North Carolina. Its subsidiary business units include NOHO, Cherryology, and RaD8 Life, and associated brands include NOHO, Higher Times, Starwalker Cafe, The Meru Sky, consumer brands such as Converse, Titleist, FootJoy, Coca-Cola, Pepperidge Farm, and practitioner and nutraceutical brands including ChiroTouch, Emerson Ecologics, Reserveage, Gaia Herbs, Organic India, and NeoCell.